You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR LIDOCAINE; PRILOCAINE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for LIDOCAINE; PRILOCAINE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00154167 ↗ Safety and Efficacy Study of NV-101 in Dental Patients Completed Novalar Pharmaceuticals, Inc. Phase 2 2003-02-01 The purpose of this study was: - to determine if NV-101 accelerates recovery from numbness compared to placebo - to evaluate safety of NV-101
NCT00355277 ↗ Local Anaesthetic Effects of Transcutaneous Amitriptyline Completed University Hospital, Clermont-Ferrand Phase 1 2005-11-01 The aim of this study is to assess the local anaesthetic effects of amitriptyline applied on the skin of human volunteers, considering the differential effects on mechanic and thermic sensitivity, the local and general tolerance, and the systemic absorption of the drug. The solution used for dilution of amitriptyline is the only one known to allow transcutaneous absorption of the drug [1]. Considering that the peripheral sensitive fibre is a possible site of action of tricyclic antidepressants for relieving neuropathic pain [2,3], this is a first step study before further assessment of the therapeutic effects of transcutaneous amitriptyline.
NCT00483990 ↗ Phase I Study of PSD502 (Lidocaine Prilocaine Spray) Applied to the Glans Penis up to Three Times a Day for 21 Days in Healthy Male Volunteers Completed Plethora Solutions Ltd Phase 1 2007-03-01 The main objective of the study is to determine the safety and tolerability of repeated application of PSD502 to the glans penis in healthy male volunteers
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for LIDOCAINE; PRILOCAINE

Condition Name

Condition Name for LIDOCAINE; PRILOCAINE
Intervention Trials
Pain 12
Premature Ejaculation 4
Contraception 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for LIDOCAINE; PRILOCAINE
Intervention Trials
Premature Ejaculation 4
Hernia, Inguinal 3
Premature Birth 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for LIDOCAINE; PRILOCAINE

Trials by Country

Trials by Country for LIDOCAINE; PRILOCAINE
Location Trials
United States 33
Egypt 8
France 5
Belgium 3
Italy 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for LIDOCAINE; PRILOCAINE
Location Trials
North Carolina 4
California 3
Utah 3
West Virginia 2
New York 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for LIDOCAINE; PRILOCAINE

Clinical Trial Phase

Clinical Trial Phase for LIDOCAINE; PRILOCAINE
Clinical Trial Phase Trials
Phase 4 24
Phase 3 10
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for LIDOCAINE; PRILOCAINE
Clinical Trial Phase Trials
Completed 40
Unknown status 11
Not yet recruiting 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LIDOCAINE; PRILOCAINE

Sponsor Name

Sponsor Name for LIDOCAINE; PRILOCAINE
Sponsor Trials
Plethora Solutions Ltd 5
Assiut University 4
Cairo University 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for LIDOCAINE; PRILOCAINE
Sponsor Trials
Other 78
Industry 12
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.